This triple-combination capsule integrates the cardiovascular benefits of Acetylsalicylic Acid (Aspirin), Clopidogrel, and Rosuvastatin into a convenient single-dose formulation. It is primarily designed to prevent heart attacks, strokes, and other cardiovascular complications in patients at high risk of atherosclerosis or blood clots.

• Acetylsalicylic Acid 75 mg: A low-dose antiplatelet that inhibits platelet aggregation, reduces inflammation, and protects the heart and blood vessels.

• Clopidogrel 75 mg: Works synergistically with aspirin to prevent clot formation, significantly lowering the risk of heart attack and stroke in patients with cardiovascular disease.

• Rosuvastatin 10 mg: A statin that reduces LDL cholesterol and triglycerides, improves HDL cholesterol, and stabilizes arterial plaques to prevent further progression of heart disease.

This capsule is ideal for patients with coronary artery disease, peripheral artery disease, or a history of heart attack or stroke, offering the benefits of dual antiplatelet therapy plus lipid management in a single capsule. The capsule form enhances ease of swallowing, absorption, and compliance, especially for long-term therapy.

By targeting both blood clot prevention and cholesterol control, this formulation provides comprehensive cardiovascular protection. It is particularly beneficial for adults at risk of atherosclerotic cardiovascular disease (ASCVD), post-heart attack patients, and those with high cholesterol or multiple cardiovascular risk factors.